Taro's Robert Carraher, brand division vice president, and marketing manager Donna Livingston reported strong sales of clotrimazole/betamethasone dipropionate cream, supported by direct mail waves to doctors and pharmacists. Carraher said Taro's version of Schering's antifungal/corticosteroid, Lotrisone, already has claimed 50 percent of the market since its May 29 approval.
COPYRIGHT 2001 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2001 Gale Group